Article

Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.

The OLIN Studies, Sunderby Central Hospital of Norrbotten, Luleå, Sweden.
COPD Journal of Chronic Obstructive Pulmonary Disease (Impact Factor: 2.62). 04/2007; 4(1):5-13. DOI: 10.1080/15412550601168358
Source: PubMed

ABSTRACT Data on the relationship between decline in lung function and development of COPD are sparse. We assessed the decline in FEV1 during 10 years among subjects with respiratory symptoms by two different methods and evaluated risk factors for decline and its relation to incident Chronic Obstructive Pulmonary Disease, COPD. A cross-sectional postal questionnaire was in 1986 sent to 6610 subjects of three age strata. All subjects reporting respiratory symptoms were invited to a structured interview and spirometry. A follow-up survey was performed 10 years later, and totally 1109 subjects performed spirometry in both 1986 and 1996. COPD was defined according to the ATS/ERS standards (FEV1/FVC < or =0.70). The decline in FEV1 was 39 ml/year in men vs. 28 ml/year in women, p = < 0.001 (-1.53 vs. -0.12 change in percent of predicted normal value over 10 years (pp), p = 0.023), among smokers 39 vs. non-smokers 28 ml/year, p < 0.001 (-3.30 vs. 0.69 pp, p < 0.001), in subjects with chronic productive cough 36 vs. not 32 ml/year, p = 0.044 (-2.00 vs. -0.02 pp, p = 0.002). Incident cases of moderate COPD (n = 83) had a decline of 62 ml/year (-12.6 pp) and 22.9% of them had a decline > 90 ml/year (-27.8 pp over 10 years). Gender-specific analysis revealed that smoking was a stronger risk factor in women than in men, while higher age was a significant risk factor in men only. In conclusion, decline in FEV1 was associated with age, smoking, and chronic productive cough, but the risk factor pattern was gender-dependent. Among incident cases of COPD the decline was steeper and close to a quarter had a rapid decline.

0 Followers
 · 
168 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, some epidemiological surveys of risk factors for chronic obstructive pulmonary disease (COPD) have been done in some regions of China, but the relevance is shown different in these surveys. A meta-analysis was undertaken to assess the relationship between smoking and COPD in Chinese population. 24 papers were included in our study. Total number of ever smokers and never smokers were 34 191 and 58 854, the number of COPD cases in each group were 5 843 and 4 874 respectively. We used meta-analysis method to analyze the selected papers quantitatively, and stratified by type of study, gender and smoking index. Risk of COPD for ever smokers is higher than never smokers (OR 2.90, 95%CI 2.22∼3.80); after stratifying by gender and smoking index, risks of COPD for male and female ever smokers are higher than male and female never smokers (OR 1.93, 95%CI 1.35∼2.77; OR 2.67, 95%CI 2.01∼3.56, respectively); risks of COPD for ever smokers who belong to different smoking index group(1∼200, 200∼400, >400, <300, ≥300 cigarettes per day*year) are all higher than never smokers (OR 2.49, 95%CI 1.66∼3.74; OR 2.91, 95%CI 2.19∼3.87; OR 4.07, 95%CI 3.17∼5.23; OR 2.39, 95%CI 1.42∼4.02; OR 3.31, 95%CI 2.99∼3.66, respectively). The risk of COPD is higher for ever smokers than never smokers in Chinese population. The risk of COPD is higher for female smokers than male smokers. The risk of COPD is higher with greater smoking index.
    The Clinical Respiratory Journal 02/2014; DOI:10.1111/crj.12118 · 2.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart failure (HF) is a syndrome that presents with increasing prevalence, and can restrict the individual as to the physical-functional, lung condition and quality of life. Check the quality of life, lung and physical limitations of patients and compare them with those in New York Heart Association (NYHA) functional class. Cross-sectional study, a sample of 66 patients (45 men). It applied a form of standardized assessment, spirometry, manovacuometry, of the six minute walk test (6MWT) and questioning the quality of life Short-Form 36 (SF-36). Patients average age of 57.95±10.96 years (Class I: 24, Class II: 27 and Class III: 15) and represented a sample with anthropometric characteristics homogeneous. For the lung condition, we observed a statistical difference in forced vital capacity (FVC), expiratory peak flow and maximal expiratory pressure (MEP). In 6MWT distance significant difference between Class I and III and between II and III (Class I: 439.27±58.85 m, Class II: 370.96±74.41 m and 268.96±83.88 m Class III), with p<0001. For the SF-36, there was a decrease in quality of life as functional disorder of the classes. Patients with IC have decreased lung condition, physical and functional capacity and quality of life proportional to the increase in the NYHA functional class.
    06/2011; 18(2):157-163. DOI:10.1590/S1809-29502011000200010
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To describe a multidimensional symptom profile in patients with stable chronic obstructive pulmonary disease (COPD) and determine whether symptom experience differed between patients with moderate or severe airflow limitations. Background: Patients with severe airflow limitation experience numerous symptoms, but little is known regarding patients with moderate airflow limitation. Methods: A multidimensional symptom profile (Memorial Symptom Assessment Scale) was assessed in 42 outpatients with moderate and 49 with severe airflow limitations. Results: The mean number of symptoms in the total sample was 7.9 (+/- 4.3) with no difference between patients with moderate and severe airflow limitations. The most prevalent symptoms with the highest MSAS symptom burden scores were shortness of breath, dry mouth, cough, sleep problems, and lack of energy in both groups. Conclusions: Patients with moderate or severe airflow limitations experience multiple symptoms with high severity and distress. An assessment of their multidimensional symptom profile might contribute to better symptom management.
    Heart and Lung The Journal of Acute and Critical Care 05/2014; 43(4). DOI:10.1016/j.hrtlng.2014.04.004 · 1.32 Impact Factor